… chemotherapy had EGFR mutation but could not get EGFR-TKIs because of the cost associated
with the drug in China, as most patients had to pay out of pocket, in turn limiting its use [3]…

… , versus gefitinib in treatment-naïve patients with advanced … analysis showed that dacomitinib
was superior to gefitinib … independent radiologic central (BIRC) review (hazard ratio [HR…

… 7 trial, there was no significant PFS and OS benefit when they were comparing afatinib with
gefitinib in older adult participants [12,13]. In the ARCHER 1050 trial, there was significant …

… a meta-analysis comparing the efficacy and safety of gefitinib in combination with chemotherapy
versus gefitinib alone in patients with advanced Non-Small Cell Lung Cancer (NSCLC). …

… gefitinib can be administered to patients with a poor performance status (PS). The differences
in the efficacy of gefitinib … the effects of gefitinib treatment in patients with advanced NSCLC …

… and gefitinib-matching placebo (n=178) or gefitinib and … gefitinib were treated and
were included in the full analysis … (18·0–23·5) in the gefitinib group. Median IRC-assessed …

… chemotherapy alone in treating non-small cell lung cancer. Medicine. 2020;99:31(e21490). …
is a meta-analysis of the literature on gefitinib and gefitinib chemotherapy, it does not directly …

… Our results showed that people given erlotinib, gefitinib,afatinib or icotinib have a longer
time before the … We classified trials using gefitinib into the following comparison groups. …

… Non–small cell lung cancer … 500 mg and gefitinib 250 mg (A + G group) or oral placebo
and gefitinib 250 mg (… Randomization was done by minimization using BioKnow—randomization …

… , most patients with lung cancer are diagnosed … gefitinib, and erlotinib for elderly patients
with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer …